Current role
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2025-12-01–present
Vin Menon
Equibles does not estimate personal net worth.
Get an email with a short summary when Apimeds Pharmaceuticals US, Inc. publishes a filing, an earnings call transcript or a press release.
Get APUS alertsAbout Vin Menon
Vin Menon is recorded as CEO and Board Member at Apimeds Pharmaceuticals US, Inc. (APUS) since December 1, 2025. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed December 2, 2025 that Vin Menon was appointed Chief Executive Officer, effective December 1, 2025. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed December 2, 2025 that Vin Menon was appointed Company Director Designee, effective December 1, 2025. Apimeds Pharmaceuticals US, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Apimeds Pharmaceuticals US, Inc. includes Sungjoon Chae (CEO and Board Member), Youngjik Cho (CEO, Chairman and Board Member), Eric Sherb (CFO) and 3 others.
“as of the Effective Time, Erik Emerson resigned as Chief Executive Officer of the Acquiror, and Dr. Menon, an individual designated by the Company, was appointed as the new Chief Executive Officer of the Acquiror, effective as of the Effective Time.”
“the Company designated two individuals, Dr. Vin Menon and Amir Dossal (the "Company Director Designees"), to be appointed as directors to replace the vacancies on the Board created by the Resigning Directors, and the Company Director Designees were appointed to the Board effective as of the Effective Time.”
Affiliation history
-
Current
2025-12-01–present
-
Current
2025-12-01–present
Company network
Leadership on record at Apimeds Pharmaceuticals US, Inc.
- Sungjoon Chae CEO, Board Member
- Youngjik Cho CEO, Chairman, Board Member
- Eric Sherb CFO
- Amir Dossal Board Member
- Junyoung Yu Board Member
- Minguk Ji Board Member